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In recent years, (de)carboxylases that catalyze reversible (de)
carboxylation have been targeted for application as carboxyla-
tion catalysts. This has led to the development of proof-of-
concept (bio)synthetic CO2 fixation routes for chemical produc-
tion. However, further progress towards industrial application
has been hampered by the thermodynamic constraint that
accompanies fixing CO2 to organic molecules. In this Review,
biocatalytic carboxylation methods are discussed with em-
phases on the diverse strategies devised to alleviate the
inherent thermodynamic constraints and their application in
synthetic CO2-fixation cascades.
1. Introduction
Carbon dioxide is an inexpensive and renewable carbon source
that can be harnessed as a building block to generate industrial
chemicals, green fuels, pharmaceutical precursors, agrochem-
icals, and polymers.[1–3] Utilizing CO2 in this way reduces
dependence on fossil fuels, promoting sustainable chemistry
and anthropogenic CO2 recycling.
[4] The current climate change
threat demands new strategies to mitigate excess atmospheric
CO2, potentially by converting it into useful commodities.
Several catalytic methodologies for the conversion of CO2 to
economically viable fuels and chemicals have sought to develop
cost-effective strategies for either the reduction of CO2
[5,6] (e. g.,
to methane, methanol, or dimethyl ether) or the incorporation
of CO2 into organic molecules.
[7] The latter route is otherwise
referred to as synthetic CO2 fixation and represents an
immensely attractive sustainable synthetic approach for the
utilization of CO2 as renewable C1 building block.
[8–10]
In practice however, efficient synthetic CO2-fixation routes
are rare, owing to both the thermodynamic barrier associated
with fixing CO2 to organic compounds, as well as the high
energy requirement for substrate activation. Recent efforts to
address these limitations have led to the development of
promising chemocatalytic strategies which have shown poten-
tial for industrial exploitation.[8] Notably, the use of bases such
as KOtBu, Cs2CO3, aluminum-based Lewis acids, and transition
metals to promote C  H carboxylation have resulted in signifi-
cant improvements with respect to synthetic scope, yields, and,
in some cases, green credentials.[9,11–14] However, these chemo-
catalytic carboxylation routes are still associated with imperfect
regioselectivity and harsh operating conditions, including
elevated temperatures and pressures.
In contrast, biological CO2 fixation reactions are often highly
selective and occur under mild conditions. Several functionally
diverse families of carboxylases have evolved to catalyze
physiologically important CO2-fixing reactions, playing pivotal
roles in the natural carbon cycle.[16] A key enzyme in this regard
is ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO)
which catalyzes carboxylation of ribulose-1,5-bisphosphate
(RuBP); a central transformation step in photosynthesis.[17,18] The
exciting chemistry performed by carboxylases, especially those
occurring in autotrophic pathways (e.g., RuBisCO) have inspired
chemists to develop novel biomimetic carboxylation
reactions.[11,19] However, attempts to exploit nature’s abundant
carboxylases by developing synthetic carboxylation routes have
garnered slow progress, attributed to strict substrate specificity,
poor catalytic efficiency and requirement of complex, expensive
or unstable co-factors.[18] Nevertheless, some natural carbox-
ylases have been investigated as in vitro and in vivo carbox-
ylation catalysts for the synthesis of target compounds.[20–23]
Recent focus has thus been targeted towards the develop-
ment and application of (de)carboxylases which catalyze
reversible decarboxylation in microbial biosynthetic and degra-
dation pathways.[16,24–27] These enzymes frequently exhibit
relaxed substrate tolerance, simple cofactor requirements,
stability and inherent evolvability (e.g., towards broad substrate
tolerance, stability, high catalytic efficiency, solvent tolerance
and high regio- and stereoselectivity). Since the carboxylation
process is often thermodynamically disfavored, the exploitation
of decarboxylases as carboxylation catalysts must be supported
by effective strategies to overcome the thermodynamic con-
straints associated with the uphill carboxylation reaction.
In this Review, we examine recent efforts aimed at
developing synthetic biocatalytic carboxylation methods with
emphasis on (i) proof of concept application of (de)carboxylases
for one-step biocatalytic synthesis of target carboxylic acids at
analytical, semi-preparative and preparative scales; (ii) diverse
strategies devised to alleviate the inherent thermodynamic
constraint of CO2 fixation, (iii) the exploitation of these enzymes
to develop synthetic biocatalytic cascades that can provide
access to carboxylic acids and their derivatives through CO2
fixation, and (iv) opportunity to expand the biocatalytic (de)
carboxylation toolbox by exploiting and evolving prenylated
flavin (prFMN)-dependent decarboxylases as one of the promis-
ing routes for enzymatic carboxylation. This Review is not
intended to be exhaustive, hence does not cover CO2-fixation
routes employing metabolic and genetic engineering ap-
proaches as these have been recently reviewed elsewhere.[28,29]
Similarly, the Review does not cover aspects relating to the
biochemistry and physiological roles of (de)carboxylases which
have previously been reviewed by our group and
others.[24,25,27,30]
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2. An Overview of Synthetically Targeted (De)
carboxylases
A diverse panel of (de)carboxylases with distinct substrate
specificities (Scheme 1), ranging from those acting on phenolic
substrates (Scheme 1a), heteroaromatic and nonphenolic aro-
matic compounds (Scheme 1b) to (functionalized) aliphatic
substrates (Scheme 1c) have been biochemically characterized
by different groups. Given the high energy requirement for
substrate (de)activation during the (de)carboxylation process,
most (de)carboxylases employ an organic cofactor such as
thiamine pyrophosphate (TPP), biotin, (prenylated) flavin, pyr-
idoxal, and/or divalent metal ions including Zn2+, Mg2+, Mn2+,
Fe2+ and Co2+.[31]
For example, thiamine pyrophosphate (TPP) is frequently
employed by decarboxylases acting on (branched) α-keto
acids.[32] Members of (TPP)-dependent decarboxylases such as
pyruvate decarboxylase (PyDC) and branched α-keto acids
decarboxylase (KdcA) have recently been investigated for
application as carboxylation catalysts on oxyfunctionalized
aliphatic compounds.[33,34] Other aliphatic carboxylases such as
NADPH-dependent carboxylating enoyl-thioester reductases
(ECRs)[21,35,36] and the recently developed glycolyl-CoA carbox-
ylase (GCC) have been exploited towards the carboxylation of
CoA thioester-containing aliphatic substrates. The latter enzyme
has been developed from a biotin-dependent propionyl-CoA
carboxylase.[37,38]
Another class of decarboxylases emerging as an attractive
set of (de)carboxylation biocatalysts are the UbiD-family of
enzymes. These enzymes catalyze reversible (de)carboxylation
using the newly discovered prenylated flavin (prFMN)
cofactor,[26,30,39] and have shown promise for application as (de)
carboxylation catalysts.[40–43] One example is the prFMN-depend-
ent dihydroxybenzoic acid (de)carboxylase (AroY), which cata-
lyzes the prFMN-dependent para-carboxylation of catechols,[40]
while another distinct class of prFMN-dependent enzymes,
fungal ferulic acid decarboxylases (FDCs) catalyze the prFMN-
mediated reversible (de)carboxylation of a broad range of
acrylic acid derivatives.[41] FDCs are a particularly exciting class
of (de)carboxylases owing to their potential for carboxylation of
nonactivated terminal alkenes and (hetero)aromatic com-
pounds.
The versatile UbiD-enzyme family also feature members that
catalyze the regioselective (de)carboxylation of (hetero)
aromatic compounds. These include; 2,5-furandicarboxylic acid
decarboxylase (hmfF),[42] pyrrole-2-carboxylate decarboxylases
(P2CDC),[44,45] indole-3-carboxylate decarboxylase (I3CDC),[46] and
phenyl phosphate carboxylase (PhPC).[47] Emerging evidence
has shown/predicted that these enzymes employ the prFMN
cofactor in their catalysis, in a similar fashion to characterized
members of the UbiD enzyme family.[39]
Several decarboxylases employ divalent metal ions without
requiring any organic cofactors. For example, 2,6-dihydroxyben-
zoic acid decarboxylases (2,6-DHBDs)[48] and 2, 3-DHBDs[49]
utilize Zn2+ and Mg2+/Mn2+ respectively to facilitate the
carboxylation of dihydroxybenzenes, while the aliphatic carbox-
ylase, phosphoenolpyruvate carboxylase (PEPC)[50,51] employs
either Co2+, Mg2+, or Mn2+ . in its carboxylation process.
Finally, while cofactors are often essential in most enzymatic
(de)carboxylation reactions, a few families of decarboxylases
operate without the use of any cofactors,[31] relying on the
active site architecture for catalysis. These enzymes use a
general acid-base mechanism, often involving substrate-assist-
ed catalysis, typically by the substrate phenolic moiety. Phenolic
acid decarboxylases (PADs), which catalyze the direct carbox-
ylation at the β-carbon of the vinyl group of hydroxystyrenes,[52]
are a notable example of synthetically useful cofactor-free
decarboxylases.
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Scheme 1. A selection of synthetically promising (de)carboxylases acting on distinct but diverse substrate groups and showing site of carboxylation: (a) acting
on phenolic compounds; (b) acting on heteroaromatic and nonphenolic aromatic compounds; (c) acting on aliphatic compounds. Organic/divalent metal ions
cofactors presented in red. Organic cofactors: ATP=adenosine triphosphate; prFMN=prenylated flavin; TPP= thiamine pyrophosphate; NADPH=nicotina-
mide adenine dinucleotide phosphate (reduced). Enzymes: PhPC=phenylphosphate carboxylase; pHBD=para-hydroxybenzoic acid decarboxylase;
DBHD=dihydroxybenzoate decarboxylase; PAD=phenolic acid decarboxylase; P2CDC=pyrrole-2-carboxylate decarboxylase; I3CDC= indole-3-carboxylate
decarboxylase; HmfF=2,5-furan dicarboxylic acid decarboxylase; FDC= (fungal) ferulic acid decarboxylases; PEPC=phosphoenolpyruvate carboxylase;
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3. One-Step CO2 Fixation Routes for the
Synthesis of Carboxylic Acids
3.1. Synthesis of para-hydroxybenzoic acids through C  H
carboxylation of phenols
Following the discovery of (de)carboxylases in microbial
aromatic degradation pathways,[53] exploitation of these en-
zymes for sustainable carboxylation of aromatic compounds
began to attract attention. Initial efforts were focused on
developing efficient biocatalytic carboxylation methods that
can potentially replace the well-established Kolbe-Schmitt
approach for the carboxylation of phenol 1 (Scheme 2a).[54] In
the 1990s, the first promising biocatalytic alternative to Kolbe-
Schmitt approach was demonstrated by applying a Mn2+
-dependent phenyl phosphate carboxylase (PhPC), an enzyme
involved in phenol metabolism. PhPC catalyzes regioselective p-
carboxylation of phenylphosphate 2 to yield p-OH benzoic acid
1b,[47,55] coupling carboxylation to dephosphorylation, likely
dependent on prenylated flavin (prFMN) cofactor.[39] By employ-
ing cell-free extract containing PhPC or the partially purified
enzyme supported on low melting agar, Aresta et al. achieved
carboxylation of 2 to yield 1b affording up to 90% yield
(Scheme 2b).[55] PhPC was also applied as a carboxylation
catalyst under supercritical CO2 (ScCO2) conditions.
[56] Unfortu-
nately, the PhPC system does not catalyze direct carboxylation
of phenol 1, as an ATP-dependent phosphorylation step is
required to activate phenol prior to carboxylation, limiting
applicability.
Efforts were re-directed towards identifying reversible (de)
carboxylases capable of catalyzing direct p-carboxylation of
phenol, leading to the isolation and characterization of a
cofactor-free p-hydroxybenzoate decarboxylase from Enter-
obacter cloacae (Ec_pHBD).[57] In the presence of 3 M KHCO3, the
enzyme was shown to catalyze regioselective p-carboxylation of
1 to yield 1b, affording conversion of 19% (Scheme 2c).[57]
Yoshida et al. later characterized 3,4-dihydroxybenzoate decar-
boxylase from E. cloacae (Ec_AroY). By employing Ec_AroY as
the carboxylation catalyst and 3 M KHCO3 as CO2 source,
regioselective p-carboxylation of catechol 3 furnished the
corresponding carboxylate 3a in 28% conversion. (De)
carboxylation activity of Ec_AroY was initially only observed
with whole-cell or cell free extract, whereas the isolated enzyme
rapidly lost activity upon purification. Recent work by Payer
et al. has revealed that AroYs belong to the UbiD-like prFMN-
dependent enzyme family, and indeed, in vitro (de)carboxylase
activity of Ec_AroY was restored following reconstitution with
prFMN.[40] To showcase the synthetic scope of AroYs, Payer et al.
applied recombinant E. coli whole cells containing over-ex-
pressed Ec_AroY with 3 M KHCO3. This revealed that catechol
derivatives 3–7, bearing electron-withdrawing or -donating
groups at the meta position relative to the carboxylation site,
were converted, yielding the corresponding carboxylic acids
3a–7a in low conversion values, up to 16% (Scheme 2d). In
contrast, catechol derivatives bearing o-substituents or simple
phenols were unreactive.[40]
3.2. Synthesis of ortho-hydroxybenzoic acids by C  H
carboxylation of phenols
Several dihydroxybenzoic acid decarboxylases (DHBDs) capable
of catalyzing regioselective o-carboxylation have been charac-
terized and their synthetic applicability have been explored. For
example, by employing E. coli cells expressing a cofactor-free
salicylic acid decarboxylase from Trichosporon moniliiforme
(SAD_Tm) or its engineered variant, Kirimura and co-workers
performed a highly regioselective o-carboxylation of phenol 1
and m-aminophenol 8, yielding salicylic acid 1a and p-amino-
salicylic acid 8a respectively.[58,59] An impressive yield of up to
70% carboxylation product was obtained from 100 mM m-
aminophenol, with a supply of 2 M KHCO3 as the CO2 source.
[59]
Scheme 2. Regioselective p-carboxylation of phenylphosphate, phenol and
catechols catalyzed by reversible nonoxidative decarboxylases. (a) Kolbe-
Schmitt carboxylation method (b) Carboxylation of phenyl phosphate
catalyzed by phenyl phosphate carboxylase (PhPC)[55] (c) Biotransformation
performed with phenol decarboxylase from Enterobacter cloacae (Ec_
pHBD)[57] (d) Biotransformation performed using prFMN dependent 3,4-
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Similarly, Nagasawa and co-workers synthesized 2,6-dihydrox-
ybenzoic acid 10a by employing 2,6-dihydroxybenzoic acid
decarboxylase from Agrobacterium tumefaciens (2,6-DHBD_At)
catalyzing regioselective o-carboxylation of 1,3-dihydroxyben-
zene 10 with conversion of 30%.[60]
Within the last decade, studies from Faber’s group have
highlighted the significant synthetic potential of nonoxidative
decarboxylases for carboxylation of phenolic compounds.
Wuensch et al. investigated the substrate tolerance and
regioselectivity of three previously characterized bacterial
DHBDs for the o-carboxylation of structurally diverse simple
phenols and dihydroxybenzene derivatives.[61] Biotransformation
reactions were performed using lyophilized recombinant E. coli
whole cells expressing one of the following ortho-decarbox-
ylases: 2,3-dihydroxybenzoic acid decarboxylase from Aspergillus
oryzae (2,3-DHBD_Ao),[62] 2,6-dihydroxybenzoic acid decarboxy-
lase from Rhizobium sp. (2,6-DHBD_Rs)[60] and SAD_Tm.[58] These
enzymes display broad substrate tolerance enabling o-carbox-
ylation of several simple phenolic compounds, as well as
dihydroxybenzene derivatives 1 and 8–13. In all cases, the
enzymes displayed excellent regioselectivity (Scheme 3a).[61]
Plasch et al. further demonstrated an extended substrate scope
for these catalysts; several polyphenolic compounds were
carboxylated with good to excellent conversions of up 97%,
enabling access to a wide range of o-carboxylated (di)
hydroxyaromatic carboxylic acids 14a–22a (Scheme 3b).[63] For
example, preparative scale enzymatic carboxylation of resvera-
trol 20 was achieved, affording the carboxylated product 20a in
excellent isolated yield of 95%.[63] Of the three enzymes, 2,3-
DHBD_Ao displayed the broadest substrate scope, accepting a
wide range of phenolic compounds including those bearing
Scheme 3. Examples of regioselective ortho-carboxylation of phenolic compounds catalyzed by recombinant E. coli whole cells containing a 2,3-
dihydroxybenzoic acid decarboxylase (2,3-DHBD) reported by (a) Wuensch et al.,[61] (b) Plasch et al.,[63] and (c) Zhang et al.[64] 2,3-DHBD_Ao=2,3-
dihydroxybenzoic acid decarboxylase from Aspergillus oryzae; 2,6-DHBD_Rs=2,6-dihydroxybenzoic acid decarboxylase from Rhizobium sp. and SAD_
Tm= salicylic acid decarboxylase from Trichosporon moniliiforme. 2,3-DHBD_Fo=2,3-dihydroxybenzoic acid decarboxylase from Fusarium oxysporum.
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other reactive groups such as carbonyls 14a, 15a, and 18a, as
well as bulky polyphenolic compounds 18a–22a.[63]
Later, Zhang et al. also characterized a 2,3-DHBD from
Fusarium oxysporum (2, 3-DHBD_Fo) to further expand the
biocatalytic toolbox for o-carboxylation.[64] This homologue
exhibited tolerance for high substrate loading. Phenol, catechol
and other substituted phenolics were carboxylated at saturated
KHCO3 levels with conversion up to 46% (1a, 8b, c, 9a–c;
Scheme 3c).[64]
3.3. One-step CO2 fixation for the synthesis of heteroaromatic
carboxylic acids
In view of the prevalence of heteroaromatic carboxylic acids as
structural component in pharmaceuticals, agrochemicals, and
industrial chemicals; regioselective synthetic methodologies
that enable access to these compounds under mild reaction
conditions would be very desirable. Nagasawa and co-workers
exploited two heteroaromatic acid decarboxylases, pyrrole-2-
carboxylate decarboxylase (P2CDC)[44,65,66] and indole-3-carbox-
ylate decarboxylase (I3CDC)[46] to demonstrate proof-of-concept
regioselective C  H carboxylation of pyrrole and indole respec-
tively. The P2CDC enzyme from Bacillus megaterium (P2CDC_
Bm) catalyzed regioselective carboxylation of pyrrole 23 to
pyrrole-2-carboxylic acid 23a with supply of saturated solution
of KHCO3.
[65,66] Optimization of the P2CDC-based process for
carboxylation of pyrrole in a batch reactor enabled preparative
scale reaction at 300 mM substrate loading and up to 80% yield
was achieved (Scheme 4a).[65] Matsuda et al. further showed that
whole cells of B. megaterium containing P2CDC_Bm can be
adapted for carboxylation of 23 under ScCO2; affording 59%
yield after 1 h, a significant improvement when compared to
conversion of 7% obtained with reaction under atmospheric
pressure. A continuous flow process employing the immobilized
form of the biocatalyst in a flow reactor under 6.5 MPa CO2
pressure enables carboxylation of pyrrole with a yield of 24�
7 μmolh  1; representing a 25-fold improvement when com-
pared to a corresponding batch process.[67]
Recently, Payne et al. characterized a P2CDC from Pseudo-
monas aeruginosa (P2CDC_Pa or PA0254/HudA).[68] PA0254/
HudA share 44% sequence identity with P2CDC_Bm and
catalyze a prFMN-dependent reversible (de)carboxylation
pyrrole-2-carboxylate 23 as well as related furan and thiophene
analogues, albeit in much lower efficiency for the latter
compounds.[45] However, benzo-fused heteroaromatic com-
pounds such as indole-2-carboxylate and indole-3-carboxylate
were rejected. Carboxylation biotransformation employing
P2CDC_Pa (PA0254/HudA) as the catalyst and supplying 1 M
KHCO3/1.5 MPa CO2 afforded up to 55% conversion of 23 to
23a.[45]
Another distinct heteroaromatic decarboxylase, indole-3-
carboxylate decarboxylase from Arthrobacter nicotianae (I3CDC-
At) was shown to catalyze the regioselective carboxylation of
indole 24 to furnish indole-3-carboxylic acid 24a; conversion of
34% was achieved when 3 M KHCO3 was supplied as the CO2
source (Scheme 4b).[46]
Emerging data on the characterization of prFMN-dependent
enzymes and phylogenetic analysis suggest P2CDCs and the
I3CDC_At belong to the UbiD enzyme family and employ
prFMN-mediated (de)carboxylation,[39,45] although this remains
to be verified for I3CDC.
The Leys group have further exploited prFMN catalysis to
significantly expand the product profile for heteroaromatic
carboxylic acids. For example, Payne et al. reported the
carboxylation of furoic acid 25 to the corresponding dicarbox-
ylic acid (2,5-furandicarboxylic acid (FDCA, 25a)) using purified
thermotolerant Pelotomaculum thermopropionicum HmfF
(PtHmfF) and 1 M bicarbonate, affording conversion of up to
about 4% (Scheme 4c).[42] Compound 25a was also generated
under gaseous CO2 at 32 bar pressure albeit at a significantly
lower conversion when compared to reaction employing
elevated bicarbonate concentration as the CO2 source. A
substrate profiling study monitoring decarboxylation by HPLC
or by H/D exchange reveals that PtHmfF also displayed
tolerance towards pyrrole-2-carboxylate 23a, and oxazole-2-
carboxylic acid as substrates but not the thiophene analogue. In
addition, an activating carboxylic acid group is required as the
corresponding unsubstituted heteroaromatics are nonreactive.
Hence, like P2CDCs and I3CDC_At, the synthetic scope of HmfF
is limited.
Scheme 4. Regioselective carboxylation of heteroaromatics: (a) Carboxylation
of pyrrole by pyrrole-2-carboxylate decarboxylase from Bacillus megaterium
(P2CDC_Bm).[44] (b) Carboxylation of indole by indole-3-carboxylate-decar-
boxylase from Arthrobacter nicotianae (I3CDC_At).[46] (c) Carboxylation of
furoic acid to yield 2,5-furandicarboxylic acid (FDCA) catalyzed by reversible
prFMN-dependent decarboxylase HmfF[42] (d) (de)carboxylation of benzo-
fused O-, N-, and S-containing heteroaromatic carboxylic acids catalyzed by
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Recently, structure-guided protein engineering was used to
evolve Aspergillus niger ferulic acid decarboxylase (AnFDC) into
a broad spectrum heteroaromatic (de)carboxylase (AnFdc I327S/
N) catalyzing reversible decarboxylation of oxygen-, nitrogen-,
and sulfur-containing benzo-fused heteroaromatic carboxylic
acids 26a–28a (Scheme 4d).[43] The AnFdc I327S variant was
exploited as the carboxylation catalyst for the C  H functionali-
zation of benzofuran 26 to the corresponding carboxylate
derivatives through cascade biocatalysis.[43]
3.4. Synthesis of α,β-unsaturated carboxylic acids by C  H
carboxylation of (hydroxy)styrenes
Faber and co-workers developed a novel synthetic method for
β-carboxylation of p-hydroxystyrene derivatives. Bacterial phe-
nolic acid decarboxylases (PADs) were shown to catalyze the
direct carboxylation of the vinyl group (sp2C  H) of hydroxystyr-
enes in the presence of KHCO3 as co-substrate.
[52,61] PADs
displayed excellent regio- and stereoselectivities by acting
exclusively on the β-carbon of the alkene moiety of hydrox-
ystyrenes, generating (E)-p-coumaric acid derivatives. Applica-
tion of recombinant E. coli whole cells expressing novel and
previously characterized bacterial PADs[52,61,69] exhibited regiose-
lective β-carboxylation of a wide variety of p-hydroxystyrene
derivatives 29–36 in the presence of 3 M KHCO3, yielding the
corresponding carboxylic acids 29a–36a in low to moderate
conversions (Scheme 5).[52] Related substrates bearing methyl
substitution at the α-carbon or β-carbon to the carboxylic
group (as in 37a–39a) were unreactive, likely due to the steric
constraint posed by the substituent.
In agreement with the substrate-assisted mechanism of PAD
(Scheme 6), related compounds lacking the p-hydroxy group
(e.g., styrene/cinnamic acid) or the vinyl moiety (e.g., phenol)
did not react. Indeed, PAD-mediated (de)carboxylation relies on
simple acid-base catalysis,[12] rendering a para-hydroxy phenolic
functional group obligatory for activity. This severely limits the
scope of application of bacterial PADs. In contrast, fungal ferulic
acid decarboxylases (FDCs) can act on ‘nonphenolics’ by virtue
of a distinct prFMN-dependent mechanism (Scheme 6).
Scheme 5. Regioselective β-carboxylation of (p-hydroxy)styrenes (a) Regioselective β-carboxylation of para-hydroxystyrenes by applying E. coli whole cells
expressing co-factor free phenolic acid decarboxylases (PADs)/ferulic acid decarboxylase (FDC) from bacterial sources.[52] Enzymes: Phenolic acid decarboxylase
(PAD) from Bacillus amyloliquefaciens (PAD_Ba); from Mycobacterium colombiense (PAD_Mc), and ferulic acid decarboxylase (FDC) from Enterobacter sp. (FDC_
Es). For clarity, conversion values (%) obtained with PAD_Ba, PAD_Mc and FDC_Es have been given in black, blue, and pink, respectively. (b) Regioselective β-
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Substrate profiling studies have established that a phenolic
moiety is not essential for FDC-prFMN-mediated (de)
carboxylation activity. Indeed, recent work has shown that
several acrylic acid derivatives bearing plain phenyl, substituted
aromatic, heteroaromatic as well as aliphatic groups were
efficiently decarboxylated by the prFMN-dependent fungal
FDCs to provide access to structurally diverse terminal alkenes
in up to 99% conversion.[41,73]
However, the synthetic utility of fungal FDCs as carboxyla-
tion catalysts is limited by the severe thermodynamic constraint
of this reaction, prFMN-bound AnFdc-or its variant from
Saccharomyces cerevisiae (ScFdc)-catalyze the carboxylation of
styrene in the presence of 1–3 M KHCO3 or NH4HCO3 to form
cinnamic acid, affording conversion of up to 5% (Scheme 5b).
The reversibility of the FDC-catalyzed carboxylation inspired the
development of novel enzymatic CO2-fixation cascades for the
C  H β-carboxylation of nonactivated styrene applying AnFdc/
ScFdc as the carboxylation catalysts[43] (see Section 5).
Scheme 6. Mechanism of FDC-catalyzed (de)carboxylation of phenylacrylic acids (e.g., cinnamic acid) vs PAD-mediated (de)carboxylation of phenolic
analogues (e.g., p-coumaric acid). (a) Mechanism for decarboxylation of cinnamic acid by covalent catalysis using the prFMN iminium involving an initial 1,3-
dipolar cycloaddition between the dipolarophile of the substrate and the azomethine ylide-like species of prFMNiminium resulting in a cycloadduct species Int1.
The Glu282 side chain mediates the protonation step to form Int3.[70,71] The decarboxylation product styrene is released through a cycloelimination process. (i–
v)=1,3-dipolar cycloaddition, decarboxylation, CO2 to Glu 282 exchange, protonation and cycloelimination, respectively. (b) A general acid-base mechanism
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3.5. Synthesis of short-chain aliphatic carboxylic acids
In primary metabolism, several distinct families of (de)
carboxylases catalyze the (de)carboxylation of oxy-functional-
ized aliphatic C2  C6 intermediates such as: acetate, glycolate,
glyoxalate, oxalate, pyruvate, malonate, succinate, fumarate,
malate and oxaloacetate to mention a few. In some interesting
cases, these pathways feature tandem carboxylation-decarbox-
ylation steps catalyzed by a carboxylase-decarboxylase pair. For
example, biotin and ATP-dependent acetyl CoA carboxylase and
β-keto acyl synthase catalyze tandem carboxylation-decarbox-
ylation reactions in fatty acid biosynthesis,[24] whilst in gluconeo-
genesis tandem carboxylation/decarboxylation reactions are
mediated by ATP and biotin-dependent pyruvate carboxylase
and PEP carboxykinase (PEPCK), catalyzing carboxylation of
pyruvate to oxaloacetate and the subsequent decarboxylation
and phosphorylation respectively. Although originally thought
to perform irreversible decarboxylation, studies of the Bacillus
subtilis isozyme of PEPCK has shown that in the absence of the
enzyme pyruvate kinase, PEPCK can perform the reverse
reaction, albeit in a highly limited fashion.[74] In some plants,
PEPCK homologues catalyze decarboxylation of oxaloacetate in
the Hatch-Slack pathway of C4 carbon fixation,
[75] or the
Crassulacean acid metabolism (CAM) pathway.[75,76] Whereas PEP
carboxylase (PEPC) catalyzes the opposing reaction to PEPCK,
the carboxylation and dephosphorylation of PEP to form
oxaloacetate.[50]
From a biotechnological application viewpoint, these (de)
carboxylases have been largely explored to optimize microbial
biosynthetic pathways to improve production titers of the
native pyruvate-based compounds through genetic manipula-
tion and synthetic biology approaches.[16,22,23,77–79] However,
there are limited reports of biocatalytic exploitation of these
aliphatic carboxylic acid (de)carboxylases to develop one-step
carboxylation methods for the preparation of short-chain
carboxylic acids and derivatives.
3.5.1. One-step synthesis of α-keto acids and aliphatic
dicarboxylic acids
Miyazaki et al. demonstrated the synthetic utility of the thi-
amine pyrophosphate (TPP)-dependent pyruvate decarboxylase
(PyDC) as carboxylation catalyst to convert acetaldehyde 41
and CO2 to pyruvic acid 41a. Following optimization of reaction
conditions, particularly pH and bicarbonate concentration, the
PyDC-catalyzed carboxylation of 41 afforded 41a in up to 81%
conversion (at pH 11 and 500 mM bicarbonate as a CO2 source;
Scheme 7a).[33]
Other aliphatic acid decarboxylases that have recently been
investigated include the TPP-dependent branched-chain α-keto
acid decarboxylase (KdcA) from the Ehrlich pathway. Skerra and
co-workers showed that KdcA can be applied as carboxylation
catalyst to synthesize L-methionine from the precursor alde-
hyde 42 and gaseous CO2 at 2 bar pressure through KdCA-
catalyzed carboxylation (to 42a; Scheme 7b), linked to an
enzymatic reductive amination. The amination step was
incorporated to alleviate the effect of the unfavorable chemical
equilibrium of the CO2 fixation step.
[34]
Chang et al. also demonstrated the use of PEPC for the
in vitro carboxylation of phosphoenolpyruvate (PEP) 43 to
generate oxaloacetate 43a (Scheme 7c). It was reported that
the conversion value was improved when carbonic anhydrase
(CA) was incorporated to increase the availability of CO2
(hydrated form, HCO3
  ) in the reaction buffer.[80] Del Prete et al.
utilized a similar approach, applying a thermostable PEPC and
CA for the conversion of PEP and CO2 to produce oxaloacetate
even at 60 °C.[81]
Scheme 7. One-step CO2-fixation transformations for oxy-functionalized aliphatic compounds. (a) Carboxylation of acetaldehyde to yield pyruvic acid with
CO2, catalyzed by pyruvate decarboxylase.
[33] (b) One-step CO2-fixation route to the corresponding α-keto acid, although, owing to severe thermodynamic
limitation of this reaction, significant carboxylation was only achieved when the carboxylate was removed from the equilibrium by further enzymatic
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3.5.2. Carboxylation of CoA thioesters
Erb and co-workers have devoted a significant efforts towards
developing biocatalytic routes for the carboxylation of CoA
esters, especially through the development and exploitation of
crotonyl-CoA carboxylase/reductase (CCR), carboxylating enoyl-
thioester reductases (ECRs) and recently, glycolyl-CoA carbox-
ylase (GCC). Following their discovery of crotonyl-CoA carbox-
ylase/reductase (CCR) from Rhodobacter sphaeroides in 2007,
Erb et al. explored the synthetic utility of CCR as a carboxylation
catalyst.[82] Initially, they showed that cell extracts of R.
sphaeroides incubated with NaHCO3, NADPH, and acetyl CoA,
the C2 CoA ester, acetyl-CoA 44 was converted into the C5-
carboxylate ethylmaonyl-CoA 46a, in multistep transformations
involving a carboxylation step, affording almost full conversion
within 1 h of incubation (Scheme 8a).[82]
Crotonyl-coA carboxylase/reductase (CCR) was identified as
the carboxylating enzyme, and shown to catalyze the ATP-free
reductive carboxylation of crotonyl-CoA to ethylmalonyl-CoA
with NADPH as reductant (Scheme 8b).[82] The heterologous
expression of the ccr gene in E. coli allowed the isolation of the
carboxylase/reductase CCR, which was applied as the carbox-
Scheme 8. Enzymatic carboxylation of coenzyme A (CoA) thioesters. (a) Conversion of acetyl CoA into ethylmalonyl CoA through a multistep reaction
involving a carboxylation step, catalyzed by a Rhodobacter sphaeroides lysate.[82] (b) Carboxylation of propionyl CoA catalyzed by crotonyl CoA carboxylase/
reductase (CCR)[82] (c) Substrate scope of carboxylating enoyl thioester reductases (ECRs). Three ECRs (RevT from Streptomyces sp., CinF from Streptomyces sp.,
and EcrSh from Streptomyces hygroscopicus) showed broad substrate scope for α,β-unsaturated CoA-thioesters. RevT, CinF, EcrSh afforded moderate to
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ylation catalyst to convert crotonyl-CoA 46+CO2 to ethyl-
malonyl-CoA 46a. CCR also showed tolerance towards acryloyl-
CoA.[35]
Erb and co-workers also investigated carboxylating enoyl-
thioester reductases (ECRs) for the carboxylation of a wide
range of α,β-unsaturated CoA-thioesters.[36] Nine ECRs were
assessed against a structurally diverse substrate library (46–59).
Whereas all nine ECRs carboxylated C4 and C5-enoyl-CoAs,
three of the enzymes, RevT and CinF from Streptomyces sp. and
EcrSh from Streptomyces hygroscopicus, showed a remarkably
broad carboxylation substrate scope, affording the carboxylated
products 46a, 47a, and 49a in moderate to excellent
conversion (up to >99% conversion; Scheme 8c).[36] They also
established that these enzyme families are evolvable by
pinpointing active site residues controlling substrate specificity.
Thus, rationally designed variants exploring substitutions of
these residues improved catalytic efficiency towards, for
example, bulkier substrates, such as 48 and 55.[36]
Furthermore, Erb’s group successfully improved the weak
promiscuous carboxylation activity of a medium-chain dehydro-
genase/reductase (MDR) by protein engineering. Using propion-
yl-CoA synthase from Erythrobacter sp. NAP1 and acrylyl-CoA
reductase from Nitrosopumilus maritimus as template, they
generated a rationally designed single point mutant with
improved carboxylation efficiency, comparable to natural
carboxylases.[83] A notable feature of CCR, ECRs and the
engineered promiscuous MDR-carboxylase is that they do not
require ATP. The required nicotinamide cofactor can easily be
supplied at scale using well established NAD(P)H cofactor
recycling,[84] making preparative scale reactions feasible.
Finally, the group has recently reported the development of
glycoyl-CoA carboxylase (GCC) using weak promiscuous carbox-
ylation activity of biotin-dependent propionyl-CoA carboxylases
from Methylorubrum extorquens (MePCC) towards the carbox-
ylation of glycoyl-CoA to tartronyl-CoA (Scheme 8d) as a
starting template for protein engineering.[37] Using rational and
directed evolution coupled with ultrahigh throughput micro-
fluidic screening, weak carboxylation (catalytic) efficiency of
glycoyl-CoA of MePCC was improved by up 900-fold to yield
two very active variants, GCC M4 and M5, which also remedied
the problematic/undesirable ATP hydrolysis associated with the
wild type MePCC.[37]
4. Strategies to Improve Carboxylation Yields
4.1. Use of elevated CO2 levels as co-substrate
Several groups have explored the use of elevated concen-
trations of bicarbonate (HCO3
  , as CO2 source) to shift the (de)
carboxylation equilibrium towards the carboxylation direction.
For example, Wieser et al. investigated the effect of varying the
concentration and the type of HCO3
  /CO3
2  salts as CO2 source
towards improving carboxylation conversions for P2CDC-cata-
lyzed reactions.[65] They observed that carboxylation conversion
improves with increasing HCO3
  concentration, attaining peak
conversion level at saturating HCO3
  concentration (>2.5 M). In
contrast, CO3
2  salts, such Li2CO3, Na2CO3, and K2CO3, were not
effective as carboxylation agents (Table 1).
In a more recent study, Wuensch et al. corroborated the
findings of Wieser et al., establishing that for decarboxylase-
catalyzed carboxylation reactions, conversion is affected by the
type of bicarbonate salt as well as its concentration. For
example, 2,6-dihydroxybenzoic acid decarboxylase from Rhi-
zobium sp. (2,6-DHBD_Rs) and Mycobacterium colombiense
(PAD_Mc) showed clear preference for KHCO3 and bicarbonate
salts of ammonia, with peak conversions achieved at saturating
[HCO3
  ], whereas aminoguanidine bicarbonate was a poor co-
substrate.[85] Consequently, for most decarboxylase-catalyzed
carboxylation biotransformation reactions, HCO3
  is supplied at
(near) saturating concentrations (typically 1–3 M HCO3
  ).
Wuensch et al. suggest that there is a correlation between
the performance of the bicarbonate salt and the Hofmeister
ranking. The latter ranks cations and anions based on their
ability to salt-out proteins,[86] showing the kosmotropic (stabiliz-
ing) and chaotropic (destabilizing) effects of an ion. In general,
the observed conversions attained by 2,6-DHBD_Rs conformed
to the cation Hofmeister series with kosmotropic ions such as
tetraethylammonium bicarbonate affording higher conversions
(37%), whereas chaotrophic ions such as Li+ and guanidinium
providing significantly lower conversions (ca. 6% and 0%
respectively). A similar trend was observed when PAD_Mc was
employed as the carboxylation catalyst. It is also possible that
water solubility of these salts at the reaction pH as well as the
slow interconversion of the molecular species, CO3
2  , HCO3
  ,
CO2(aq) may contribute to the performance of the salts as
carboxylating agents.
It has been highlighted that carboxylation methods employ-
ing gaseous CO2 as the carboxylating agent, instead of large
excess of bicarbonate, can eliminate the need to use wasteful
amount of bicarbonate salts.[87] In addition, carboxylation using
pressurized CO2 may simplify downstream reaction work-up
and product isolation. Until recently, examples demonstrating
the utilization of gaseous CO2 for biocatalytic carboxylation
have only been successful when used in combination with
elevated concentrations of HCO3
  .[88–90] However, Faber and co-
workers recently applied pressurized CO2 as the sole carboxylat-
Table 1. Enzymatic carboxylation utilizing different bicarbonate salts to
supply CO2 to (de)carboxylase enzymes.
Buffer Carboxylation conversions [%][a]
P2CDC[a] 2,6-DHBD_Rs[b] PAD_Mc[b]
(CH3)4NHCO3 – 38 12
KHCO3 82 36 30
NH4HCO3 77 34 33
CsHCO3 – 26 28
NaHCO3 66 26 22
choline-HCO3 – 24 28
BaCO3 14 – –
CaCO3 13 – –
Li2CO3 <1 6 5
Na2CO3 <1 – –
K2CO3 <1 – –
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ing agent for direct o-carboxylation of resorcinol catalyzed by
2,3-DHBD_Ao and SAD_Tm. They found that the H2CO3
generated from dissolved CO2 in the reaction buffer causes
significant acidification, hence inactivating the biocatalyst. To
address this, they optimized the reaction buffering system to
alleviate the pH change therefore allowing carboxylation
conversion of up to 68% with pressurized CO2 (~30–40 bar) as
the sole carboxylating agent.[87]
4.2. Carboxylation under supercritical CO2 conditions
Supercritical fluids are emerging as important media for
enzymatic transformations.[91] Among other advantages, super-
critical fluids can allow reaction conditions to be adapted by
manipulating pressure and/or temperature, which can improve
the solubility of substrates and products. This is particularly
attractive for enzymatic carboxylation; the use of supercritical
CO2 (scCO2) as carboxylation reaction medium drastically
improves CO2 availability and thus potentially carboxylation
yield. In addition, CO2 has a low critical temperature of 304 K
and a critical pressure of 72.9 atmospheres,[90] allowing super-
critical state to be reached under ambient conditions suitable
for enzymatic transformation.
Given these advantages, the potential for scCO2 as a
medium for enzymatic carboxylation has been investigated.
Matsuda et al. applied whole cells of B. megaterium (PYR2910)
containing P2DC as the carboxylation catalyst for enzymatic
carboxylation of pyrrole in a scCO2/H2O biphasic system.
[90] The
yield of the carboxylation reaction was much higher at
pressures above the critical pressure of CO2 (7.6 MPa) (Table 2),
this was also trialed with immobilized cells.[67] Similarly, 2,6-
dihydroxybenzoate decarboxylase from Pandoraea sp. 12B-2
(2,6-DHBD_Ps) has also been tried in scCO2, applying the
enzyme as whole-cell preparation. In this instance, 30 mM 2,6-
dihydroxybenzoate was formed from 100 mM 1,3-dihydroxy-
benzene (30% conversion), a slightly lower yield when
compared to conversion obtained (45%) with reaction per-
formed with 3 M KHCO3 as a CO2 source.
[88]
One important factor to be considered is biocatalyst stability
under supercritical conditions. Enzyme inactivation may occur
and in turn may result in poor carboxylation yield under scCO2.
For example, Mn2+-dependent phenylphosphate carboxylase
from T. aromatica afforded significantly lower conversion under
scCO2 conditions (5% conversion)
[56] when compared with
reaction performed at 100 mM NaHCO3 (90% conversion).
[55]
Optimization of reaction conditions to enhance catalyst
stability and allow scCO2 exploitation as a suitable medium for
enzymatic carboxylation are key. One study shows that
pyruvate decarboxylase loses 80% of its decarboxylation
activity following treatment with pressurized CO2 at 60 bar,
[92]
with enzyme inactivation mitigated through the use of
excipients such as glycerol and trehalose, and immobilization
on an ion exchange polymer. These interventions led to a
dramatic improvement in the biocatalyst stability.
4.3. Effect of pH
Reaction pH for enzymatic carboxylation reactions can influence
the availability of CO2 in the reaction buffer, as a pH-dependent
equilibrium exists between the different dissociation species
(H2CO3, CO2(aq), HCO3
  and CO3
2  ). Given that different (de)
carboxylases preferentially utilize CO2(aq) or its hydrated for
HCO3
  as co-substrate, identifying and maintaining optimal
reaction pH that enhances availability of the desired molecular
species is important especially in a closed reaction vessel/
system. The reaction pH can also alter the stability of the
biocatalysts and other reaction components such as the
substrate and the product, in turn affecting the performance of
the whole system.
Wuensch et al. gauged the effect of pH on PAD-catalyzed
carboxylation reactions, revealing increasing conversions at
between pH 6.5 and 9.5, while a DHBD-catalyzed carboxylation
biotransformation showed a pH optimum between 7.5 and
8.5.[85] At higher pH values, the promiscuous hydration activity
mediated by PADs was enhanced, leading to the formation of
hydration product as the major product. Miyazaki had also
previously found that higher conversion values were achieved
with increasing pH, for a PyDC-catalyzed carboxylation
reaction.[33] When the reaction pH was varied between pH 8.5
and 11.5, they found that the carboxylation conversion peaked
at pH 11; which can be attributed to the higher rate of
hydrolysis of α-lactoylthiamin at higher pH, typical of thiamine
dependent-systems.[33] In contrast, other decarboxylases have
been shown to exhibit optimal (de)carboxylation activity at
slightly acidic pH values.[34] It is however difficult to maintain
the optimal reaction pH throughout the duration of the
reaction, especially under conditions required to favor carbox-
ylation (e.g., at saturating bicarbonate concentrations and/or
pressurized CO2). Identifying appropriate aqueous reaction
buffers represents a successful approach to cushion the effect
of pH changes.[34,87]
4.4. Use of organic cosolvent
Organic co-solvents have the ability to modify water activity,
leading to changes in kinetic and thermodynamic behavior of
enzymatic reactions.[93,94] Hence, the use of organic co-solvents
can potentially affect the biocatalytic carboxylation reaction
Table 2. Enzymatic conversion of pyrrole into pyrrole-2-carboxylate in
scCO2.
Pressure [MPa] Vol.[a] [mL] pH t [h] Conversion [%]
0.1 (atmospheric) 0.5 5.5 1 7
0.1 (atmospheric) 0.5 5.5 3 6
10 (supercritical) 0.5 5.5 1 54
10 (supercritical) 0.5 5.5 3 55
10 (supercritical) 0.0 5.5 3 0
10 (supercritical) 1.0 5.5 3 59
10 (supercritical) 0.5 7.0 1 59
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rate and the (de)carboxylation equilibrium. Nagasawa and co-
workers examined the effect of several organic co-solvents
revealing that addition of 10–20% (v/v) acetone increased the
rate of enzymatic carboxylation towards the formation of 2,6-
dihydroxybenzoate catalyzed by 2,6-DHBD_Ps. However, the
effect on conversion yields following longer incubation was not
significant.[88] Wuensch et al. found that the efficiency of 2,6-
DHBD-catalyzed o-carboxylation was increased by up to ~50%
with the addition of 20% (v/v) of water-miscible co-solvents
and polyethylene glycols.[85] In particular, DMF, 1,2-dimeth-
oxyethane, acetone, acetonitrile, N-methyl-2-pyrrolidone and
1,4-dioxane improved conversion values. However, β-carboxyla-
tion biocatalysts appear to be less tolerant to organic co-
solvents investigated.[85] Thus, the use of organic co-solvents
can increase the efficiency of biocatalytic carboxylation reac-
tion, however the compatibility of different co-solvents has to
be determined for the decarboxylase employed.
4.5. In situ CO2 capture for carboxylation
Amine based technology for the capture of CO2 is increasingly
receiving attention.[95,96] Pesci et al. exploited the reversible
reactivity of amines with CO2 to capture CO2 in situ for
carboxylation in a biotransformation vessel (Scheme 9a).[97] They
linked an in situ amine-mediated CO2 capture to a decarbox-
ylase-catalyzed carboxylation reaction and monitored the
carboxylation efficiency with this system vis-a-vis that lacking
the amine-mediated CO2 capture component.
[97] Biotransforma-
tion reactions were performed under high pressure, and a
typical reaction mixture contained 2,3-DHBD_Ao as lyophilized
E. coli cells, buffered amine solution and substrate (catechol),
while CO2 was slowly supplied up to a pressure of 50 bar.
Carboxylation of catechol performed in 1 M KHCO3 aqueous
solution was compared to reaction performed in 1 M triethyl-
amine (TE)/CO2 solution. They observed that both reaction rate
and conversion values were higher with the TE/CO2 reaction
medium (ca. five- and two-fold, respectively). Although a
number of primary, secondary and tertiary amines produced
similar improvements as the TE/CO2, these conditions appear to
be specific to catechol, as the same system did not result in
improvements in conversion when applied to the carboxylation
of other aromatic compounds.[97] This may be due to enzyme
inhibition/inactivation at such high concentration of TE, thus
less reactive substrates are less likely to be efficiently carboxy-
lated.
In a similar study utilizing triethanolamine (TEA)-based CO2
at a significantly higher concentration (3 M), and employing a
CO2 fine bubble gassing technique, Ohde et al. achieved subtle
improvements in conversion with the same enzyme system.
They attributed this improvement (16.1% to 25.7%) to the
higher concentration of amine mediator (1 M vs 3 M), which in
turn allowed CO2 to be supplied as ‘fine bubbles’.
[98]
In another study, the carboxylation yield was shown to
improve with the TEA-mediated CO2 in situ delivery linked to a
decarboxylase(2,6-DHBD_Rs)-catalyzed carboxylation of resorci-
nol, when this system was coupled to a downstream in situ
chemical carboxylate precipitation.[99] A quaternary ammonium
salt was employed as the precipitant as has been previously
demonstrated by Ren et al.[100] However, the efficiency of the
system reported by Ohde et al. depends on the type and
concentration of the amine mediator, the downstream deriva-
tion agent, and reaction conditions.[98]
Other investigators have explored the use of carbonic
anhydrase (CA) for CO2 capture and delivery for enzymatic
carboxylation in one-pot system. CA accelerates the intercon-
version of CO2 and water into bicarbonate, thus ensuring a
continuous supply of the co-substrate for carboxylation.
Incorporation of CA to (de)carboxylase-catalyzed carboxylation
reaction to improve the efficiency of biocatalytic carboxylation
has been investigated.
Faber and co-workers explored the carbonic anhydrase
(CA)-mediated CO2/(bi)carbonate equilibration process to en-
hance carboxylation yield, but with no success.[61] It is possible
that CA was inhibited by the aromatic substrates/other reaction
components/conditions in their system or that CO2/bicarbonate
equilibrium was not rate limiting. In contrast, Del Prete et al.
successfully constructed an in vitro nonlinear one-pot enzy-
matic cascade combining a recombinant phosphoenolpyruvate
carboxylase (PEPC) and a bacterial carbonic anhydrase, which
was reported to improve the efficiency of PEPC-catalyzed
carboxylation of PEP 43 to 43a (Scheme 9b).[81] Hwang et al.
immobilized PEPC and CA in microbead compartments to
develop a stabilized PEPC-CA carboxylation nonlinear cascade
that improved the efficiency of the system and recyclability of
the catalysts.[101]
In general, despite the potential of the in situ CO2 capture
and delivery systems, mediated by amines or CAs for enzymatic
carboxylation, only subtle improvements in the carboxylation
efficiency have been demonstrated so far. This suggests the
Scheme 9. In situ CO2 capture and utilization for carboxylation. (a) Linking
amine-mediated CO2 capture to carboxylation reaction catalyzed by 2,3-
dihydroxybenzoic acid decarboxylase from Aspergillus oryzae (2,3_DHBD_
Ao).[97] (b) Linking in situ capture of CO2 mediated by carbonic anhydrase
and its utilization for the carboxylation of phosphoenoylpyruvate (PEP)
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CO2/bicarbonate equilibrium may not be the rate limiting factor
in the carboxylation reactions investigated or that the optimal
reaction conditions for these orthogonally connected cascade
reactions are yet to be identified.
5. Biocatalytic CO2-Fixation Cascades for
Preparation of Carboxylate Derivatives
Decarboxylases have been frequently employed as selective
and beneficial defunctionalization catalysts in enzymatic and
chemoenzymatic synthetic cascades.[102–106] Even more appeal-
ing is the prospect of exploiting reversible decarboxylases as
C  H functionalization tools to generate carboxylate derivatives
from simple precursors through cascade biocatalysis. This
prospect has proven practically challenging, given the inherent
thermodynamic constraint associated with the carboxylation
step. In recent years, linear enzymatic and chemo-enzymatic
synthetic CO2-fixation cascades have been designed to simulta-
neously alleviate the thermodynamic ‘inertia’ of CO2 fixation
and to achieve an economically viable synthetic purpose.
Typically, the (de)carboxylase-catalyzed carboxylation reaction
is linked to at least a second transformation step. The latter
derivatizes the carboxylation product, often through an irrever-
sible reaction or an energetically favorable downstream reac-
tion, removing it from the (de)carboxylation equilibrium. This
tandem process often explores the reactivity of the carboxylic
acid group or other functional groups proximal to the
carboxylic acid moiety such that the derivatized/downstream
product is no longer reactive with the decarboxylase. Artificial
synthetic CO2-fixation pathways developed in these ways are
often inspired by and mimic natural microbial synthetic path-
ways; and often recruit suitable biocatalysts from diverse
sources/pathways and in some cases abiotic catalysts or
reagents.
5.1. Chemoenzymatic synthetic derivatization approaches
Ren et al. exploited the reactivity of the carboxylic acid group
towards quaternary ammonium salts.[100] The latter when added
to a decarboxylase-catalyzed carboxylation biotransformation,
reacts with the carboxylic acid moiety of the carboxylation
product to form an insoluble salt, thereby removing it from the
equilibrium (Scheme 10a). The resulting salt can subsequently
be hydrolyzed using a strong acid to regenerate the carboxylic
acid. Using the carboxylation of resorcinol 10 catalyzed by 2,6-
DHBD_Rs as the model reaction, eight quaternary ammonium
salts and tetrabutylphosphonium were screened as precipitat-
ing agents. Tetrabutylammonium bromide performed as the
superior precipitating agent under the conditions investigated.
The decarboxylase-catalyzed carboxylation reactions containing
2 and 5 equivalents of tetrabutylammonium bromide afforded
80 and 97% conversions, respectively, representing significant
improvements when compared to conversion obtained (37%)
with a control reaction lacking the precipitant. Initial reaction
rates were comparable for reaction containing or lacking the
precipitant, indicating that enzyme velocity is unaffected.
However, while the reaction containing the precipitants pro-
gressed to near completion after 24 h, the yield with the control
reaction reached a plateau. Product recovery was enabled by
Scheme 10. Enzyme-catalyzed CO2 fixation linked to chemical derivatization of the carboxylate product. (a) A strategy applying quaternary ammonium salt to
shift the reaction equilibrium towards 1,6-DHBD_Rs-catalyzed carboxylation of resorcinol. The carboxylation step is linked to the precipitation of the
carboxylate in one pot. The product was recovered by acid hydrolysis. 1,6-DHBD_Rs=1,6-dihydroxybenzoic acid decarboxylase.[100] (b) Pyruvate:ferredoxin
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acid hydrolysis, hence 2,6-dihydroxybenzoic acid was isolated in
yield of up 72%. Carboxylation of catechol was also accom-
plished using this approach, in this case dodecyldimeth-
ylbenzylammonium chloride or tetradecyldimeth-
ylbenzylammonium chloride was used as the precipitant.[100] In
addition, the precipitating quaternary ammonium compound is
recoverable through extraction with an appropriate organic
solvent (e.g., chloroform). Zhang et al. has recently applied this
strategy to improve carboxylation conversion values employing
2,3-DHBD_Fo as the carboxylation catalyst,[64] and Ohde et al.
showed that this in situ crystallization approach improved
performance of their amine-mediated CO2 capture-carboxyla-
tion system under optimized conditions.[99]
The in situ carboxylate precipitation of Ren et al. may be
adaptable for use as a generic approach to improve carbox-
ylation yield, although an appropriate precipitating agent may
need to be identified for each product type. Crucially, it is yet to
be established whether this approach can be extended to other
(de)carboxylases as this system has only thus far been
demonstrated for related DHBDs.
Other chemical derivatizing agents have been explored for
enzymatically produced carboxylates as a strategy to improve
carboxylation conversion. For example Witt et al. recently
devised a chemical derivatization strategy to drive the carbox-
ylation of acetyl CoA 44 by using pyruvate:ferredoxin oxidor-
eductase (PFOR) as the carboxylation catalyst.[107] PFOR catalyzes
the interconversion of 44 and CO2 to pyruvate 41a, however
the carboxylation (oxidative) reaction is severely disfavored.
Given that the carboxylation product 41a contains an α-keto
group which can react with semicarbazide to form the
corresponding semicarbazone condensation product 41b; Witt
et al. hence targeted the reactivity of the α-keto group of the
formed pyruvate by adding semicarbazide as a derivatizing
agent in the carboxylation biotransformation (Scheme 10b).
Using this strategy and employing non-native ferredoxin or
methylviologen as cofactor, the derivatized carboxylation
product (pyruvate semicarbazone, 41b) was detected in
conversion of up to 53%.[107] This approach demonstrates that
enzymatic CO2 fixation to form carbonyl group-containing
products, such as α-keto acids, can be linked to semicarbazide
condensation to generate biologically active semicarbazones.
Alternatively, PFOR-catalyzed carboxylation can be linked to
other enzymatic transformation targeting the α-keto group, for
example through asymmetric transamination/reductive amina-
tion or carbonyl reduction to yield the corresponding optically
pure amino acids or hydroxy acids, respectively.
5.2. Synthetic enzymatic CO2-fixation cascades for
derivatization and valorization
5.2.1. Conversion of aldehydes into hydroxy/amino acids via
α-keto acids
Tong et al. developed a multienzyme system for the conversion
of CO2 and acetaldehyde 41 to 41a which is subsequently
reduced to L-lactic acid 41c. The synthetic concept employs
ethanol 41b as a ‘smart’ substrate; alcohol dehydrogenase
(ADH)-catalyzed oxidation of 41b generates the carboxylation
substrate, 41 as well as the reductant NADH (Scheme 11).
The multistep process involves (i) an NAD-dependent
oxidation of 41b to generate 41 and NADH, catalyzed by
alcohol dehydrogenase; (ii) carboxylation of 41 by pyruvate
decarboxylase (PyDC) using carbonate/bicarbonate buffer as
CO2 source, forming 41a; (iii) NADH-dependent enantioselective
reduction of 41a to generate 41c, and NAD+ achieving redox
neutral NAD(H) regeneration (Scheme 11). Using this approach
in a batch process and with continuous feeding of 41b, 41% of
ethanol was converted into 41c, albeit after 4 days.
The concept of using ethanol as the smart substrate is
elegant and economically attractive. However, a simpler two-
step linear process linking acetaldehyde carboxylation and
pyruvate reduction, and employing alternative NADH cofactor
recycling systems (e.g., glucose dehydrogenase-based systems)
may address the poor cofactor recycling turnover observed
with the system described by Tong et al.
Skerra and co-workers have also exploited an enzymatic
cascade to demonstrate the application of a TPP-dependent
decarboxylase KdcA for CO2 fixation. By linking KdCA-catalyzed
CO2 fixation of an aldehyde (e.g., methional, 42) to reductive
amination of the formed keto-acid 42a, catalyzed by a trans-
aminase (ydL) or an amino acid dehydrogenase (LeuDH or
PheDH), L-methionine 42b and related amino acids were
accessed (Scheme 12). Conversion of up to 40% was attained
after 48 h incubation at 2 bar CO2 pressure and 200 mM
NaHCO3 (or 500 mM NH4HCO3).
[34] A notable issue concerns the
incompatibility of reaction conditions, especially with respect to
identifying buffer systems that ensure compatible reaction pH
for the decarboxylase and the amination steps. In addition,
incorporation of NAD(P)H co-factor recycling system for the
dehydrogenase step can improve applicability of the system,
while the product profile may further be extended to N-alkyl
Scheme 11. Enzymatic CO2-fixation cascade for the conversion of ethanol
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amino acids by employing N-alkyl amino acid
dehydrogenases[109] as the amination catalysts.
5.2.2. Conversion of nonactivated aromatic compounds into
alcohols, amines, and amides
The versatility and evolvability of prFMN-dependent fungal
ferulic acid decarboxylases (FDCs) provide an opportunity to
expand the synthetic scope of biocatalytic carboxylation
reactions, for example towards functionalization of nonacti-
vated aromatic compounds. Significant insights into
prFMN[39,70,71,110,111] and FDC biochemistry[30,112] and (de)
carboxylation substrate scope[41] supported development of
FDC-based carboxylation routes to enable access to industrially
prevalent carboxylate derivatives including aldehyde, alcohols,
amides and amines from simple nonactivated aromatic com-
pounds by biocatalytic CO2-fixation cascades.
[43] To address the
severe equilibrium limitation encountered with the one-step
FDC-catalyzed carboxylation reaction, the FDC-mediated CO2
fixation[43] was linked to carboxylate reduction, the latter step
catalyzed by carboxylic acid reductases (CARs).[113–115] Further
valorization of the process was achieved through functional
group interconversion.[116,117] The intermediate aldehyde is
converted into the corresponding alcohol or amine through
carbonyl reduction (catalyzed by endogenous alcohol dehydro-
genase) or reductive amination catalyzed by reductive
aminases[118] (Scheme 13a–c). Thus, a three-step cascade involv-
ing AnFDC-catalyzed carboxylation, CAR-catalyzed carboxylate
reduction and subsequent enzymatic carbonyl reduction/reduc-
tive amination, implemented as a one-pot biotransformation,
converted styrene 40 into the corresponding allylic alcohol 40c
or allylic amine 40d via cinnamic acid 40a and cinnamaldehyde
40b intermediates, respectively (Scheme 13a–c). These systems
afforded high conversion values (up to 95%) to the target
products, even at low bicarbonate concentration (<100 mM).[43]
This strategy was also extended to the C  H functionalization of
heteroaromatic scaffolds such as benzofuran 26 albeit in lower
conversions; in this instance (Scheme 13e), an engineered
heteroaromatic (de)carboxylase (AnFDC I327S) was applied as
the carboxylation catalyst.[43]
Furthermore, the (de)carboxylase-CAR CO2-fixation system
was extended towards the synthesis of amides 40e and 26e
from 40 and 26, respectively, by linking the recently developed
CAR-catalyzed amidation reaction (NADPH-free CAR-catalyzed
process)[119] to the FDC-catalyzed CO2 fixation (Scheme 13d,e).
Notably, NH4HCO3 buffer served as source for both CO2 and NH3
required for the carboxylation and amidation steps, respec-
tively. This process however resulted in lower conversion,
generating the corresponding amide in up to 15% (Sche-
me 13d,e), perhaps owing to the low efficiency of the CAR-
mediated amidation reaction. Recently, amide bond-forming
biocatalysts have attracted significant attention, and more
efficient and substrate promiscuous amide bond-forming
enzymes are emerging.[120–122] These amidases may be explored
as alternative amidation catalysts in the synthesis of amides by
CO2 fixation.
The enzymatic carboxylation linked to CAR represents
potentially a generic approach given the remarkable substrate
profile of CAR enzymes[113,123,124] and the versatility of aldehyde
products as intermediates to access a wide range of other
functional groups and conjugation products.
Scheme 12. One-pot enzymatic cascade for the conversion of aldehyde into amino acid involving CO2-fixation step catalyzed by TPP-dependent decarboxylase





1797ChemSusChem 2021, 14, 1781–1804 www.chemsuschem.org © 2021 The Authors. ChemSusChem published by Wiley-VCH GmbH
Wiley VCH Donnerstag, 15.04.2021
2108 / 196904 [S. 1797/1804] 1
5.3. Synthetic in vitro CO2 fixation cycles for chemical
production
The Calvin-Benson-Bassham (CBB) cycle of plants, algae and
various autotrophic microorganisms is responsible for more
than 90% of global natural CO2 fixation, with the rest converted
via alternative CO2 fixation pathways. Despite this naturally
existing prevalence, the application of CO2-fixing enzymes and
pathways for converting CO2 into value-added multi carbon
products has been limited in chemical and biotechnological
applications. As with natural CO2-fixation processes, a familiar
bottleneck is the efficiency of the carboxylating enzyme and
attempts to improve abundant natural carboxylases have
achieved only limited success. In vitro cascade biocatalysis
Scheme 13. Enzymatic CO2-fixation cascades for the conversion of aromatic compounds into alcohols and amines.
[43] (a) CO2-fixation cascades enabling the
conversion of styrene into the corresponding allylic alcohol and amine.[43] (b) One-pot three-step enzymatic CO2-fixation cascade for the conversion of styrene
into cinnamyl alcohol, involving a sequence of Fdc-catalyzed carboxylation, CAR-catalyzed carboxylate reduction, and carbonyl reduction catalyzed by
endogenous alcohol dehydrogenase.[43] (c) One-pot three-step artificial CO2-fixation cascade involving a sequence of Fdc-catalyzed carboxylation, CAR-
catalyzed carboxylate reduction and reductive aminase(RedAm)-catalyzed reductive amination, enabling the conversion of styrene into the corresponding
secondary amines; reaction contained (NH4)HCO3 as CO2 source and cyclopropylamine as the primary amine source, and incorporated GDH-based recycling of
NADPH.[43] (d) One-pot artificial CO2-fixation cascade enabling the conversion of styrene into the corresponding cinnamide involving AnFDC-catalyzed
carboxylation linked to CAR-catalyzed amidation using NH4HCO3 as source of both CO2 and NH3. (e) CO2-fixation cascades enabling the conversion of
benzofuran into the corresponding alcohol, amine, and amide featuring similar conditions to those for (b), (c), and (d) respectively but employing the
engineered heteroaromatic (de)carboxylase AnFDC I327S as the carboxylation catalyst.[43] TpCAR=Tsukamurella paurometabola carboxylic acid reductase;
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provides an alternative approach to create completely artificial
CO2 fixation pathways that are kinetically or thermodynamically
favored and can be tuned towards production of economically
viable chemicals. To tap into this potential, more efficient
carboxylases must be identified to support synthetic CO2-
fixation artificial cycles.
Having previously developed and showcased the synthetic
potential of enoyl-CoA carboxylase/reductase (ECR) for a one-
step carboxylation reaction, Erb and co-workers exploited this
carboxylase to develop a novel artificial enzymatic CO2-fixation
cycle to a target product. ECR enzymes possess a broad
substrate range, are oxygen-insensitive, and require only the
ubiquitous redox cofactor NADPH to catalyze the fixation of
CO2.
By performing retrobiosynthetic analysis (possibly inspired
by the work of Bar-Even et al.[125]), Schwander et al. constructed
an artificial crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA
(CETCH) cycle[23] which was further developed into a fully
functional cycle using the typical design/build-test-optimize
cycles. The CETCH cycle recruits enzymes from a wide range of
different biological sources, and the combination of such
diverse enzymes into a synthetic pathway posed several
challenges. Schwander et al. addressed these problems step-
wise, through reaction optimization and protein engineering,
improving the process through the different optimized versions
of the cycle (CETCH 1–5.4). By version 5.4, the CETCH cycle has
been well-tailored for the synthesis of malate 73 from
propionyl-CoA 60 (Scheme 14). A total of 17 enzymes from nine
different organisms were included, with 13 making up the core
cycle, and 4 allowing for cofactor regeneration, metabolite
proofreading, and rate measurement. Three of the core
reactions were created by rational active-site engineering of
existing enzyme scaffolds to catalyze the desired activities.
CETCH 5.4 relies solely on the reductive carboxylation of enoyl-
CoA esters by the application of ECRs and displays a CO2
fixation rate of 5 nmolmin  1mg  1 of core cycle proteins. This
rate is comparable to reported attempts to measure the CBB
cycle in cell extracts, which display reported rates between 1 to
3 nmolmin  1mg  1.[23] The CETCH pathway represents a success-
ful in vitro reconstitution of a synthetic enzymatic network for
the conversion of CO2 into organic products.
Further work expanding on the application of the CETCH
system is reported by Miller et al.[126] They developed a partially
synthetic thylakoid membrane-based energy-module (TEM)
which can be applied to a range of ATP and NADPH dependent
enzymatic systems such as CETCH. The TEM consists of
thylakoid membranes derived from spinach (Spinacia oleracea)
which, when supplemented with ferredoxin, and an external
light source, are capable of the light dependent synthesis of
ATP and NADPH, with specific activities of 6.5�
0.5 mMmin  1mg  1 chlorophyll (Chl) and 3.41�
0.01 μmolmin  1mg  1 total Chl, respectively.
Initial trials of the light-driven TEM chemical energy
generation system demonstrated its applicability to in vitro CO2
fixation, demonstrating a greater than 3 orders of magnitude
increase in activity in comparison to other recent attempts to
link CO2 fixation to isolated thylakoid membrane complexes.
When coupled with either the NADPH dependent crotonyl-
coenzyme A (CoA) carboxylase/reductase (CCR), or the ATP
dependent propionyl-CoA carboxylase (PCC), the TEM system
displays consistent light-driven CO2 fixation of between 5.1 and
5.2�0.2 μMmin  1mg  1 Chl.[126]
In addition to its ability to power single-step enzymatic CO2-
fixation systems, the TEM construct has been shown to be
applicable in driving complete metabolic cycles for the
continuous fixation of CO2. The combination of 16 enzymes in a
modified CETCH cycle, with a glyoxylate/hydroxypyruvate
reductase (Ghr) from E. coli, allowed for the TEM-driven
production of 156 mM glycolate from 120 mM acceptor
molecule.[126] These results demonstrate that the synthetic
CETCH cycle can be functionally coupled to the native energy
machinery of photosynthesis in a fully integrated fashion using
light energy to form multi-carbon compounds from CO2.
Recently, Scheffen et al. exploited the synthetic utility of
their engineered GCC M4 variant to experimentally accomplish
a previously designed hypothetical tartronyl-CoA (TaCo) CO2-
Scheme 14. Artificially developed CETCH cycle applied to the synthesis of malate. The multienzyme cascade employs 17 enzymes catalyzing 13 linear
enzymatic steps including two reductive carboxylation steps catalyzed by CCR, and additional auxiliary steps for cofactor recycling. A 520 μL reaction was
capable of fixing 1080 μM CO2 and afforded 540 μM malate in 90 min.
[23] PCO=propionyl-CoA oxidase; CCR=crotonyl-CoA carboxylase/reductase; MCL=β-
methylmalyl-CoA lyase; MAS=malate synthase. Propionyl-CoA: 60; acrylyl-CoA: 70; methylmalonyl-CoA: 70a; crotonyl-CoA: 46; ethylmalonyl-CoA: 46a;
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fixation pathway.[37,127] The TaCo pathway converts 74 (C2
compound) via a carboxylate intermediate 74a to glycerate
75b (C3) through an enzymatic cascade involving a key CO2-
fixation step catalyzed by GCC M4 (Scheme 15a).[37] A more de
novo synthetic process was developed starting from glycolate
75 en route to glycerate synthesis (Scheme 15b). 75 can readily
be accessed from 2-phosphoglycolate and propionyl-CoA
through the Calvin-Benson-Bassham (CBB) cycle and the
artificially developed CECTH respectively.[37] The TaCo pathway
also enabled a novel pathway for recycling of polyethylene
terephthalate (PET) wastes such as ethylene glycol 76. By
extending the TaCo system with two upstream additional
enzymatic steps, ethylene glycol 76 can be converted into
glycerate 74b (Scheme 15c).[37]
6. Exploiting prFMN’s Catalytic Capabilities:
Expanding the Biocatalytic (De)carboxylation
Toolbox
6.1. Development of broad spectrum hetero(aromatic)
carboxylic acid (de)carboxylases
To expand the (hetero)aromatic carboxylation toolbox, a
structure-guided semi-rational protein engineering approach
was used to evolve the well-studied prFMN-dependent Aspergil-
lus niger Fdc (AnFdc).[43] This work aimed to develop broad
spectrum heteroaromatic (de)carboxylases that can provide
access to structurally diverse oxygen-, nitrogen- and sulfur-
containing heteroaromatic carboxylates and their derivatives.
First, using the decarboxylation of cinnamic acid as a model
reaction, Aleku et al. screened a library of (hetero)aromatic acids
to identify heteroaromatic carboxylates that competitively
inhibited the native reactions. In this way, they identified
benzofuran, indole, benzothiophene carboxylates 26a–28a as
well as naphthoic acid 81a as competitive ‘inhibitors’/alternate
substrates of AnFdc. To gain structural insights into the binding
behavior of these compounds, crystallographic studies were
performed. Analysis of crystal structure complexes of AnFdc
with (hetero)aromatic acid ‘inhibitors’ versus complexes with
the native cinnamic acid substrate highlights active site residues
constituting steric hindrance and inhibiting the productive
binding of the aromatic acid substrates. These residues were
subjected to site-saturation mutagenesis, leading to the identi-
fication variants at M238 and I327 showing up to 150-fold
improvement over the weak activity observed for the wild-type
enzyme. Substrate profiling of the I327S/N variants revealed
remarkably broad substrate scope towards the decarboxylation
of O-, N-, and S-containing heteroaromatic carboxylic acids,
26a–28a and 79a–83a (Scheme 16).[43]
The AnFdc I327S/N variants are a valuable addition to the
heteroaromatic carboxylation toolbox and extend considerably
the potential synthetic scope of biocatalytic carboxylation to
access a wide range of heteroaromatic carboxylates. A proof of
concept application of the AnFdc I327S variant was demon-
strated for C  H functionalization of benzofuran through a novel
cascade reaction.[43] Crucially, this work highlights the evolv-
ability of the Fdc enzyme class, which can further be exploited
to extend the synthetic scope and improve catalytic efficiency.
6.2. Towards biocatalytic regioselective C  H carboxylation of
unactivated arenes
The regioselective carboxylation of benzene and naphthalene
remains a challenging reaction given the entropic requirement
of this transformation. Kanan and co-workers recently devel-
oped Cs2CO3
  mediated CO2 fixation process that afforded the
C  H carboxylation of benzene. However, this process required
Scheme 15. Artificially developed TaCo CO2-fixation cascade and its application in de novo synthesis. (a) TaCo-based enzymatic cascade enabling conversion
of glycolyl-CoA to glycerate.[37] (b) Conversion of glycolate to glycerate using a TaCo based enzymatic cascade. (c). Conversion of ethylene glycol to glycerate
in a 4-step TaCo-based enzymatic cascade. Enzymes: GCS=glycolyl-CoA synthetase; GCC=glycolyl-CoA carboxylase; TCR= tartronyl-CoA reductase;
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molten conditions and generated a mixture of benzoate,
phthalates, and tri- and tetracarboxylates.[11] (De)carboxylase-
based CO2-fixation routes are conceived as alternative green
and regioselective methods for the functionalization of these
recalcitrant aromatic compounds. However, identifying enzyme
candidates capable of catalyzing (de)carboxylation of benzene/
naphthalene remains a difficult task.
In recent studies, putative UbiD-like benzene (de)
carboxylase and naphthalene (de)carboxylase have been sug-
gested to be responsible for the weak carboxylase activity
observed in cultures capable of degrading benzene and
naphthalene respectively.[128,129] It has been proposed that the
degradation of these compounds occurs via an initial carbox-
ylation reaction, although biochemical characterization and
in vitro activity of these enzymes have yet to be demonstrated.
More recently, Aleku et al. identified a single point mutant
of AnFdc I327N that displays weak decarboxylation activity
towards naphthoic acid 84a affording up to 8% conversion into
naphthalene 84 and establishing it as the first enzyme to
decarboxylate naphthoic acid (Scheme 16a).[43] It is possible that
this weak naphthalene (de)carboxylating activity may be further
improved and the scope be extended towards benzene/benzoic
acids and other polycyclic aromatic hydrocarbons with subse-
quent rounds of evolution. PrFMN-mediated (de)carboxylation
of naphthoic/benzoic acid is of interest from both mechanistic
and application viewpoints and highlights the enormous
catalytic potential of these enzymes.[40,70,130–133]
6.3. Towards biocatalytic regioselective C  H carboxylation of
aliphatic hydrocarbons
In view of the industrial importance of aliphatic carboxylates
and their derivatives, site selective functionalization of aliphatic
hydrocarbons at a sp2 or sp3 carbon through C  H carboxylation
is highly attractive. In this regard, prFMN-dependent FDCs have
shown some promise albeit in the decarboxylative direction.
For example, FDCs have been shown to catalyze the decarbox-
ylation of conjugated 2,4-diunsaturated aliphatic monocarbox-
ylic acids (85a, 83a),[41] 2,4,6-tri-unsaturated acids (e.g., 2,4,6-
octatrienoic acid),[134] aliphatic acids containing isolated α,β-
mono-unsaturated acids,[135] and 2,6-dienoic acids (e.g., (E,E)-
muconic acid, 87a)[136] (Scheme 17).
Scheme 16. Engineered ferulic acid decarboxylase for (de)carboxylation of (heteroaromatic) carboxylates. Substrate profiling study of AnFdc variants I327S/N
using purified enzyme preparation of I327S (denoted as A) or I327N (denoted as B), as well as the cell-free extract of I327S (denoted as C).[43] AnFdc is a
prenylated flavin (prFMN)-dependent reversible decarboxylase from Aspergillus niger.
Scheme 17. Synthetic scope of prFMN dependent ferulic acid decarboxylases
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The substrate tolerance of FDCs and related prFMN-depend-
ent enzymes towards these aliphatic α,β- unsaturated carbox-
ylic acids promises a valuable route to extend biocatalytic CO2-
fixation portfolio to the functionalization of aliphatic substrates.
However, to date, these enzymes have yet to be exploited as
carboxylation catalysts for the functionalization of aliphatic
hydrocarbons, perhaps, due to the difficulty with handling of
these substrates (e.g., volatility, solubility) and the poor
efficiency of these enzymes towards aliphatic substrates. None-
theless, the evolvability of these enzymes should allow their
development towards efficient functionalization of aliphatic
hydrocarbons such as aliphatic terminal alkenes through C  H
carboxylation. In addition, reaction engineering and optimiza-
tion of reaction conditions may address issues with substrate
handling.
7. Conclusion and Outlook
The application of reversible (de)carboxylases as carboxylation
catalysts represents a promising biocatalytic route for the
incorporation of CO2 into organic molecules under benign
reaction conditions. With the expanding toolbox of enzymes
capable of catalyzing (de)carboxylation of a wide range of
structurally diverse molecules, there is a clear opportunity to
expand the scope of application and the product profile of
biocatalytic carboxylation methods. To build on recent achieve-
ments in biocatalytic carboxylation and to enhance the
potential of biocatalytic carboxylation processes for industrial
exploitation, several aspects of the (de)carboxylase-catalyzed
carboxylation reactions will need to be improved.
The first challenge to be met is the development of truly
benign and simple enzymatic carboxylation processes. Most
biocatalytic carboxylation reactions were demonstrated at a
saturating bicarbonate level or high CO2 pressure. The use of
pressurized CO2 for enzymatic carboxylation renders the
process hazardous and requires sophisticated equipment, while
carboxylation performed at saturating concentrations of bicar-
bonate represents a wasteful use of reagent and complicates
downstream reaction work-up. Hence, there is a need to
develop simple, safe, and mild enzymatic carboxylation meth-
ods that are efficient under low CO2 pressure/near stoichiomet-
ric concentrations of bicarbonate. In this regard, emerging
strategies devised to alleviate the disfavored thermodynamic
carboxylation equilibrium are promising. For example, it has
been possible to perform reaction at low levels of bicarbonate/
CO2 supply when the carboxylation step is coupled with
chemical/enzymatic derivatization transformations. Promising
strategies such as crystallization of the carboxylate product with
quaternary ammonium salts, or enzymatic derivatization
through biocatalytic carboxylate reduction can further be
adapted as generic platforms across different decarboxylases
families and for different substrate groups. To enhance the
viability of CO2 as a building block for industrial exploitation, it
is crucial to expand the portfolio of generic strategies available
to alleviate the inherent thermodynamic constraint of CO2
fixation.
A second challenge is the requirement to significantly
expand the substrate scope and product profile of biocatalytic
carboxylation. Despite significant addition to the biocatalyst
toolbox for carboxylation in the last decade; several substrate
groups are yet to be covered. For example, unfunctionalized
hydrocarbons as well as nonactivated aromatic compounds
whose corresponding carboxylates/derivatives feature signifi-
cantly as structural components in industrial chemicals, remain
difficult to functionalize through enzymatic carboxylation.
Directed evolution of existing enzymes as well as biochemical
screening of genomic sequences may reveal novel (de)
carboxylases with distinct substrate specificity. In addition,
functional metagenomic screening supported by appropriate
(ultra)high throughput screening and selection techniques[137,138]
can enhance access to novel decarboxylases, especially for
scaffolds that are currently inaccessible through enzymatic
carboxylation.
Finally, proof of concept preparative biocatalytic carboxyla-
tion reactions simulating conditions often used in industrial
processes, such as high substrate loading and incorporating co-
factor recycling systems will greatly enhance the attractiveness
of enzymatic carboxylation for industrial exploitation. Recent
advances in ATP-cofactor recycling systems[139–141] can be ex-
plored to improve applicability of ATP-dependent carboxylation
processes. It may be necessary to employ green organic co-
solvents or biphasic systems to improve substrate solubility,
prevent product inhibition and enhance the performance of the
system. Additionally, improving performance of enzymatic
carboxylation maybe achieved using immobilization
techniques,[142] and investigating the suitability of batch or flow
processes for individual reactions.
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